» Articles » PMID: 38323281

MiR-99b/let-7e/miR-125a Cluster Suppresses Pancreatic Cancer Through Regulation of NR6A1

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2024 Feb 7
PMID 38323281
Authors
Affiliations
Soon will be listed here.
Abstract

This experiment investigates how the miR-99b/let-7e/miR-125a cluster regulates the mechanism of NR6A1 involved in the invasive and metastatic effects of pancreatic cancer (PCa). Bioinformatics prediction and dual luciferase reporter gene assay were applied to verify the targeted relationship between miR-99b/let-7e/miR-125a and NR6A1. ASPC1 cells underwent transfection with lentiviruses to overexpress miR-99b/let-7e/miR-125a (individual or together) to explore functions of miR-99b/let-7e/miR-125a cluster governing NR6A1 in PCa. The detection of tumorigenesis was verified by tumor formation assay in nude mice in vivo, and mouse models of liver metastasis of PCa observed cell metastasis of PCa. MiR-99b/let-7e/miR-125a cluster was screened for differential expression in PCa. NR6A1 was confirmed as a target gene of the miR-99b/let-7e/miR-125a cluster. Findings demonstrated that overexpression of the miR-99b/let-7e/miR-125a cluster inhibited cell invasion, metastasis, proliferation, and tumorigenesis in PCa. Conversely, overexpressed NR6A1, a crucial gene in the miR-99b/let-7e/miR-125a cluster, promoted cell invasion, migration, and proliferation in PCa. Moreover, the overexpression of the miR-99b/let-7e/miR-125a cluster inhibited liver metastases and tumor formation. Thus, the study concludes that the miR-99b/let-7e/miR-125a cluster impedes the invasion and metastasis of PCa cells via targeting the NR6A1 gene.

Citing Articles

Transcriptomic-Based Identification of miR-125a Novel Targets in Human Hepatocarcinoma Cells.

De Leo I, Mosca N, Pezzullo M, Valletta D, Manfrevola F, Mele V Biomolecules. 2025; 15(1).

PMID: 39858538 PMC: 11763984. DOI: 10.3390/biom15010144.

References
1.
Shin J, Seo N, Baek S, Son N, Lim J, Kim N . MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy. Radiology. 2022; 303(2):351-358. DOI: 10.1148/radiol.211986. View

2.
Culig Z . miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance. Curr Cancer Drug Targets. 2021; 21(4):283-288. DOI: 10.2174/1568009620666210108103134. View

3.
Ramanand S, Chen Y, Yuan J, Daescu K, Lambros M, Houlahan K . The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer. J Clin Invest. 2020; 130(8):3987-4005. PMC: 7410051. DOI: 10.1172/JCI134260. View

4.
Dai S, Li F, Long H, Zhou Z, Luo H, Xu S . Relationship between miRNA and ferroptosis in tumors. Front Pharmacol. 2022; 13:977062. PMC: 9672467. DOI: 10.3389/fphar.2022.977062. View

5.
Zhou W, Jiang R, Wang Y, Li Y, Sun Z, Zhao H . hsa_circ_001653 up-regulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA-377. Exp Physiol. 2020; 105(12):2141-2153. DOI: 10.1113/EP088399. View